The continuing search for effective treatments for older adults with acute myeloid leukemia
Expert Review of Clinical Pharmacology · 2025
DOI: 10.1080/17512433.2025.2595682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Xavier Thomas. Beteiligte Einrichtung: Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 97 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
INTRODUCTION: The goal of treatment in older patients (≥60 years) with acute myeloid leukemia (AML) has recently switched from only improving quality of life to achieving long-term survival via prolonged therapy. Novel therapeutic drugs have indeed recently been approved and tested in combination therapy. In this setting, the combination of venetoclax with a hypomethylating agent (HMA) has emerged as a new standard of care in this patient population. AREAS COVERED: This review summarizes promising emerging strategies combining target-directed agents for the treatment of older patients with AML. A comprehensive search was made on pubmed.ncbi.nlm.nih.gov, ashpublications.org, library.ehaweb.org, and clinicaltrials.gov to look for efficacy and safety of emerging therapeutic agents. EXPERT OPINION: Over the last 5 years, the landscape of AML therapy in older patients with AML has moved from uniform approaches toward more personalized therapy based on molecularly defined subtypes that benefit from target-directed therapy. Favorable results obtained with the synergistic combination venetoclax/HMA are currently opening a new active treatment research era by adding other specific drugs to this backbone regimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.
ORCID-Profile: Xavier Thomas
Zitieren
APA
Thomas, X. (2025). The continuing search for effective treatments for older adults with acute myeloid leukemia. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2595682
Vancouver
Thomas X. The continuing search for effective treatments for older adults with acute myeloid leukemia. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2595682
BibTeX
@article{Thomas2025,
author = {Thomas, Xavier},
title = {The continuing search for effective treatments for older adults with acute myeloid leukemia},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
doi = {10.1080/17512433.2025.2595682}
}
EUVIMED